Please login to the form below

Not currently logged in
Email:
Password:

Chase

This page shows the latest Chase news and features for those working in and with pharma, biotech and healthcare.

FDA backs earlier use of Lilly’s breast cancer drug Verzenio

FDA backs earlier use of Lilly’s breast cancer drug Verzenio

Eli Lilly has picked up yet another FDA approval for CDK4/6 inhibitor Verzenio - its third in five months - as it tries to chase down Pfizer’s category-leading Ibrance.

Latest news

More from news
Approximately 1 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • Proving real-world value Proving real-world value

    Claims to be patient-centric are often contradicted by strategies that focus purely on the numbers and chase quarterly targets as a barometer of success.

  • Deal Watch November 2016 Deal Watch November 2016

    of $125m and additional regulatory and sales milestones related to Chase's phase III ready lead compound, CPC-201 for Alzheimer's, and certain backup compounds. ... equity investment, 2 year collaboration. 145. Chase Pharmaceuticals/ Allergan. fixed dose

  • Interview: Georg Toufar, Mundipharma Interview: Georg Toufar, Mundipharma

    Big pharma still chases 'new',” says Toufar. “ In some instances, such as in some orphan drugs this is amazing, but for 75 per cent of opportunities, it's not.

  • Pharma deals during August 2013 Pharma deals during August 2013

    Amidst the frenzied speculation, however, Onyx' share value jumped more than 50 per cent, inevitably discouraging would-be bidders from joining the chase.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • GW Pharmaceuticals promotes Adam George to MD GW Pharmaceuticals promotes Adam George to MD

    Giacobello, meanwhile, has 25 years experience in finance and operations, most recently as CFO for Chase Pharmaceuticals until its acquisition last year by Allergan.

  • Chase adds former Allergan execs to leadership team Chase adds former Allergan execs to leadership team

    Chase adds former Allergan execs to leadership team. Scott Giacobello and Gary Charbonneau join. ... Charbonneau joins Chase with over 25 years of experience in regulatory, quality and research and development operations.

  • Alan Kidd moves from GSK to Chase Alan Kidd moves from GSK to Chase

    Alan Kidd moves from GSK to Chase. Takes up role as business development manager. ... In his new role within Chase's business development team Kidd will be responsible for enhancing and extending its contract sales and services offering.

  • Chase Pharmaceuticals appoints former Allergan president Chase Pharmaceuticals appoints former Allergan president

    Chase Pharmaceuticals appoints former Allergan president. Douglas Ingram joins as chief executive officer. ... Ingram said: “ I am privileged to lead Chase Pharmaceuticals as we execute an elegant approach to the development of new Alzheimer's

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Strategy - It's All About Choices

    If you chase two rabbits, both will escape’: if ever there was a saying which demonstrated what is at the heart of a great strategy, then this is it. ... In my experience too many pharma companies build strategies geared to chase everything; leaving

  • Developing your patient-centric strategy

    Much of our historic effort has been led by the virus – a chase of science.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics